SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-020822
Filing Date
2023-06-12
Accepted
2023-06-12 06:11:00
Documents
16
Period of Report
2023-05-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 48114
2 ex10-75.htm EX-10.75 11423
3 ex10-76.htm EX-10.76 70409
4 ex99-1.htm EX-99.1 12378
  Complete submission text file 0001493152-23-020822.txt   365280

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bixt-20230508.xsd EX-101.SCH 3029
6 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bixt-20230508_def.xml EX-101.DEF 26179
7 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bixt-20230508_lab.xml EX-101.LAB 34240
8 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bixt-20230508_pre.xml EX-101.PRE 22367
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3593
Mailing Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494
Business Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35027 | Film No.: 231007031
SIC: 2834 Pharmaceutical Preparations